We also show that miR-217-5p directly targets EZH2 and regulates the expression of the tumor-suppressive PRC2-dependent gene targets with tumor/GSC-suppressive functions (discussed above) that are also downregulated in clinical GBM. This evidence concerns the gene EZH2 and neoplasm.